CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 110 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $621,000 | -49.5% | 200,943 | +0.7% | 0.00% | – |
| Q4 2021 | $1,229,000 | +5.1% | 199,530 | -10.7% | 0.00% | – |
| Q3 2021 | $1,169,000 | -3.4% | 223,466 | +16.9% | 0.00% | – |
| Q2 2021 | $1,210,000 | -72.3% | 191,101 | -66.2% | 0.00% | -100.0% |
| Q1 2021 | $4,365,000 | +9.2% | 564,567 | -7.5% | 0.00% | 0.0% |
| Q4 2020 | $3,998,000 | -4.7% | 610,396 | -3.3% | 0.00% | -50.0% |
| Q3 2020 | $4,196,000 | -30.4% | 630,919 | -12.8% | 0.00% | 0.0% |
| Q2 2020 | $6,029,000 | +9.0% | 723,801 | +0.4% | 0.00% | -33.3% |
| Q1 2020 | $5,530,000 | -5.2% | 720,968 | +2.7% | 0.00% | +50.0% |
| Q4 2019 | $5,836,000 | +6.4% | 702,308 | -5.6% | 0.00% | 0.0% |
| Q3 2019 | $5,487,000 | -34.3% | 743,586 | -0.1% | 0.00% | -33.3% |
| Q2 2019 | $8,352,000 | – | 744,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
| Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
| Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
| RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
| Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
| Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
| WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |